ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 116 filers reported holding ANAPTYSBIO INC in Q2 2023. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $297 | +23.8% | 16,530 | +40.2% | 0.01% | +40.0% |
| Q2 2023 | $240 | -99.9% | 11,790 | -3.7% | 0.01% | -88.1% |
| Q1 2021 | $264,000 | -29.8% | 12,240 | -30.0% | 0.08% | -21.5% |
| Q4 2020 | $376,000 | -50.9% | 17,490 | -66.3% | 0.11% | -56.0% |
| Q3 2020 | $766,000 | -48.0% | 51,940 | -21.2% | 0.24% | -51.4% |
| Q2 2020 | $1,472,000 | +58.1% | 65,910 | 0.0% | 0.50% | +27.2% |
| Q1 2020 | $931,000 | – | 65,910 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |